Deciphering the anti-senescent effects of Clioquinol: Lifespan prolongation, metabolic homeostasis, and phenotypic rehabilitation in Drosophila melanogaster.
Abstract
Clioquinol (CQ), a halogenated 8-hydroxyquinoline, was once an oral antiparasitic for intestinal amoebiasis in the 1950s-1970s but was withdrawn due to neurotoxicity. Lately, it shows activities beyond antimicrobials, like in osteoarthritis and neurodegenerative diseases, yet its anti-aging effects are unclear. This study used Drosophila melanogaster to test CQ's effects on healthy aging and age-related diseases. Results showed CQ extended lifespan in normal or high-fat diet flies, enhanced stress resistance and glycolipid metabolism, improved motility, and prevented intestinal inflammation and obesity, and alleviated age-related digestive decline. In addition, CQ also prolonged lifespan and improved motor activity in Alzheimer's flies. Gene-deficient lifespan experiments and transcriptomic analysis revealed CQ's anti-aging mechanisms involving multiple signaling pathways, such as differential gene expression in HIF-1 signaling, Notch signaling, P53 signaling, JAK-STAT signaling, FOXO signaling, and IL-17 signaling pathway, activated TNF signaling and PI3K-Akt signaling pathway, and inhibited mTOR signaling pathway. Overall, CQ shows promise as a candidate for anti-aging interventions and treating aging-related diseases.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Clioquinol extends lifespan and improves healthspan in Drosophila melanogaster through multiple signaling pathways. The study addresses mechanisms of aging and potential interventions, making it relevant to longevity research.
Author of this paper? Send a correction.